HEIDI ALTON: Open Payments
NPI 1124595509 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 31 payments from 9 companies in 2025. Trend: 2023 $1,774 · 2024 $532 · 2025 $1,165
Food & beverage: $1,165
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 8 | $535 |
| Gilead Sciences, Inc. | 8 | $190 |
| Lilly USA, LLC | 1 | $125 |
| Aimmune Therapeutics, Inc. | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $71 |
| ABBVIE INC. | 3 | $56 |
| Intercept Pharmaceuticals, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $40 |
| Ardelyx, Inc. | 1 | $31 |
Products named: REZDIFFRA, OMVOH, ZENPEP, OCALIVA, ENTYVIO, LINZESS, IBSRELA, VELSIPITY.
Industry payments across AZ — which companies pay providers there.
